|
POLR1B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.738200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.886200E-02 |
| Normal-vs-Stage2 |
8.553800E-01 |
| Normal-vs-Stage3 |
6.044600E-01 |
| Normal-vs-Stage4 |
7.825600E-02 |
| Stage1-vs-Stage2 |
4.237000E-01 |
| Stage1-vs-Stage3 |
9.150500E-02 |
| Stage1-vs-Stage4 |
1.345570E-02 |
| Stage2-vs-Stage3 |
6.038400E-01 |
| Stage2-vs-Stage4 |
1.180620E-01 |
| Stage3-vs-Stage4 |
3.199400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.185900E-02 |
| Normal-vs-AfricanAmerican |
7.567800E-01 |
| Normal-vs-Asian |
6.063600E-01 |
| Caucasian-vs-AfricanAmerican |
1.008780E-01 |
| Caucasian-vs-Asian |
2.315800E-01 |
| AfricanAmerican-vs-Asian |
6.244200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.101890E-02 |
| Normal-vs-Female |
4.714100E-02 |
| Male-vs-Female |
1.563750E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.794200E-01 |
| Normal-vs-Extreme_Weight |
3.096000E-03 |
| Normal-vs-Obese |
9.621400E-01 |
| Normal-vs-Extreme_Obese |
8.376400E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.797180E-01 |
| Normal_Weight-vs-Obese |
4.686400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.537200E-01 |
| Extreme_Weight-vs-Obese |
1.772170E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.900400E-01 |
| Obese-vs-Extreme_Obese |
8.264600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.570100E-02 |
| Normal-vs-Age(41-60Yrs) |
9.281000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.686300E-02 |
| Normal-vs-Age(81-100Yrs) |
1.444280E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.170000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.476110E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.904100E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.745500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.902500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.909430E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.783900E-02 |
| Normal-VS-Type2 PRCC |
1.164210E-01 |
| Normal-VS-KIRP CIMP |
2.357700E-02 |
| Normal-VS-Unclassified PRCC |
9.512600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.742000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.087690E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.186000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.58310000000817E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
2.541800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.595700E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.497060E-03 |
| Normal-vs-N1 |
2.372000E-02 |
| Normal-vs-N2 |
4.716400E-01 |
| N0-vs-N1 |
6.799600E-04 |
| N0-vs-N2 |
5.330600E-01 |
| N1-vs-N2 |
2.185200E-01 |
|
|
